Active	Status	Sponsor type	Region	Phase	Filter
1 Active 2 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
REGN5069 / Regeneron
2018-004730-15: A study to examine the efficacy and safety of REGN5069 in patients with pain due to osteoarthritis of the knee	Not yet recruiting	2	252	Europe	REGN5069, Lyophilisate for solution for infusion	Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc.	Pain due to osteoarthritis of the knee, Pain due to osteoarthritis of the knee, Body processes [G] - Bones and nerves physological processes [G11]